Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEJAK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,196
Award facts
- Contract value 100% obligated
- $14,195.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,195.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on January 12, 2026, with an ultimate completion date of January 13, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group specializes in distributing a comprehensive range of pharmaceutical products and medical consumables to federal agencies, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical supplies to support Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The underlying IDC, awarded on November 13, 2025, carries a ceiling value of $499.999 billion and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. As one of multiple regional prime vendor contractors within the broader $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group serves as a critical pharmaceutical supplier for Department of Defense military healthcare facilities worldwide, fulfilling diverse and specialized pharmaceutical requirements across the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FEJAK?
SPE2DU26FEJAK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DU26FEJAK worth?
The government has obligated $14,196 on SPE2DU26FEJAK.
Is contract SPE2DU26FEJAK an order under another contract?
Yes. SPE2DU26FEJAK is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEJAK competed?
The extent of competition for SPE2DU26FEJAK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award